Satellos Bioscience Risk Adjusted Performance
| MSCLF Stock | | | USD 7.30 -0.71 -8.86% |
This module presents the Risk Adjusted Performance indicator for Satellos Bioscience using available market inputs. The underlying data comes from exchange-reported trading records. Satellos Bioscience has a market cap of 15.29 M, current ratio of 1.04. Review
Correlation Analysis for broader portfolio context. Adding Satellos Bioscience to a portfolio enables side-by-side comparison with other holdings. This enables performance tracking across the full position set. Broader economic conditions can influence Satellos Bioscience's otc stock valuation — related indicators include
signals in board of governors.
Satellos Bioscience has current Risk Adjusted Performance of 0.0826.
RAP | = | (ER[a] - RFR) * STD[b])/STD[b]RFR |
| = | 0.0826 | |
Risk Adjusted Performance Peers Comparison
Risk Adjusted Performance Relative To Other Indicators
Satellos Bioscience ranks
fifth among otc stocks in risk adjusted performance across its competitive set. It is currently under evaluation in maximum drawdown across its competitive set at roughly
395.07 Maximum Drawdown per unit of Risk Adjusted Performance. Satellos Bioscience carries a
395.07 x Maximum Drawdown-to-Risk Adjusted Performance ratio
Other Technical Indicators